You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,778 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
O
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors - 2021
Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
2021-05-19
May 19, 2021
S
PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma
Recruiting
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
2020-12-16
Dec 16, 2020
S
Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas
Active, not recruiting
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-03
Jun 3, 2021
A
Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients - 2020
Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
2020-07-17
Jul 17, 2020
S
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2020-12-07
Dec 7, 2020
S
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Phoenix, Arizona
  • +4 more
2022-01-12
Jan 12, 2022
C
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +10 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2021-03-08
Mar 8, 2021
N
Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma - 2020
Withdrawn
  • Metastatic NUT Carcinoma
  • Unresectable NUT Carcinoma
  • (no location specified)
2020-09-25
Sep 25, 2020
W
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-03-12
Mar 12, 2021
S
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Active, not recruiting
  • Rhabdomyosarcoma
  • Jacksonville, Florida
  • +3 more
2021-07-01
Jul 1, 2021
M
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias - 2011
Terminated
  • Leukemia
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
2019-07-22
Jul 22, 2019
M
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT
Recruiting
  • Medulloblastoma Recurrent
  • +2 more
  • Chicago, Illinois
  • +20 more
2021-09-06
Sep 6, 2021
Z
A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.
Recruiting
  • Hemophagocytic Syndrome
  • T/NK-Cell Lymphoma
  • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
2021-08-03
Aug 3, 2021
M
Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
Recruiting
  • Lymphoma
  • Radiation Therapy
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2020-01-21
Jan 21, 2020
O
Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors
Active, not recruiting
  • Malignant Glioma
  • Minneapolis, Minnesota
  • +2 more
2021-09-15
Sep 15, 2021
H
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma - 2018
Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • etoposide phosphate
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2019-11-06
Nov 6, 2019
U
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma - 2017
Terminated
Has Results
  • Recurrent Nasopharynx Carcinoma
  • Etoposide phosphate
  • +3 more
  • Gainesville, Florida
    UF Health Shands Hospital
2019-05-29
May 29, 2019
S
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
Recruiting
  • Malignant Rhabdoid Tumor
  • Atypical Teratoid Rhabdoid Tumor
  • Los Angeles, California
  • +10 more
2021-08-30
Aug 30, 2021
S
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +5 more
2021-08-23
Aug 23, 2021
C
A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide - 2010
Terminated
Has Results
  • Carcinoma, Small Cell
  • Cleveland, Ohio
  • +5 more
2019-11-06
Nov 6, 2019
C
Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma - 2019
Completed
Has Results
  • Childhood Favorable Prognosis Hodgkin Lymphoma
  • +5 more
  • radiation therapy
  • +11 more
  • Arcadia, California
    Children's Oncology Group
2021-03-26
Mar 26, 2021
N
Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Duarte, California
  • +6 more
2022-01-05
Jan 5, 2022
S
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +12 more
2021-10-29
Oct 29, 2021
T
AC220 for Children With Relapsed/Refractory ALL or AML - 2013
Completed
Has Results
  • Lymphoblastic Leukemia, Acute, Childhood
  • Myelogenous Leukemia, Acute, Childhood
  • Los Angeles, California
  • +10 more
2020-02-07
Feb 7, 2020
C
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
2021-06-12
Jun 12, 2021